.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Novartis
Federal Trade Commission
Johnson and Johnson
US Army
Queensland Health
Express Scripts
Healthtrust
Julphar
UBS

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,601,848

« Back to Dashboard

Summary for Patent: 5,601,848

Title: Methods for the treatment of gastrointestinal disorders
Abstract:Method for the treatment of human and lower animals having an infectious gastrointestinal disorder, comprising the step of administering from about 50 to about 5000 milligrams of bismuth to said subject, per day, for from 3 to 56 days. Preferred processes also include a step for performing a diagnostic step on the subject for detection of campylobacter-like organism infection of the subject.
Inventor(s): Marshall; Barry J. (Perth, AU)
Assignee: The Procter & Gamble Company (Cincinnati, OH)
Application Number:07/070,857
Patent Claim Types:
see list of patent claims
Use; Composition;

No matches for this query

International Patent Family for Patent: 5,601,848

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Belgium904922► Subscribe
Germany3619733► Subscribe
Germany3619734► Subscribe
Germany3686361► Subscribe
Germany3686362► Subscribe
European Patent Office0206626► Subscribe
Austria79264► Subscribe
Austria79261► Subscribe
European Patent Office0206627► Subscribe
Ireland861573► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
McKinsey
Cipla
Fuji
US Army
Accenture
Federal Trade Commission
Colorcon
Harvard Business School
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot